Decreased expression of 5-HT-specific genes in adult <i>Lmx1b</i> iCKO mice. by Ning-Ning Song (233637)

Knockdown of Ube2d proteins decreases ubiquitination of EGFR in HeLa cells. by Mariya S. Liyasova (3821908)

Blocking the interaction between S100A9 protein and RAGE V domain using S100A12 protein - Fig 4 by Revansiddha Katte (5394665)

KSHV K1 mutant infected cells exhibit decreased survival following nutrient deprivation. by Penny M. Anders (3338136)

Decreased pH leads to increased nitrite-to-NO reduction. by Marcel H. Fens (595238)

SP1049C treatment decreases tumor aggressiveness. by Daria Y. Alakhova (447558)

High glucose decreases antioxidant activities in endothelial cells. by Zhaoyun Zhang (118032)

“…Measurements were performed as described in Methods. High glucose causes a decrease in multiple antioxidant enzymes. A: G6PD activity. …”

Senescent endothelial cells of hippocampus are decreased by treatment with DHT. by Hidetaka Ota (189433)

SDF-1α decreased apoptosis in neonate cardiomyocytes. by Ielham Hadad (382805)

eATP stimulation of RA decreased endothelial function. by Padmini Komalavilas (402160)

Decreasing Pronephric Fluid Flow Suppresses Anterior Migration by Aleksandr Vasilyev (150743)

Acetylation of histone H3 decreases nucleosome stability. by Alexander Gansen (404272)

Nesfatin-1 decreased excitability of GI-neurons in DVC. by Jing Dong (102657)

PCA2 decreased LPS-induced ROS generation. by Qin-Qin Wang (9211958)

Ade decreases cell viability and induces cell death. by Shujue Li (466324)

The ability of KLK6 to decrease death of murine splenocytes relates to its ability to delay the apoptotic cascade. by Isobel A. Scarisbrick (354022)

Que decreases the number of infiltrating T cells in spinal cord. by Feng Mei (143817)

“…<b>E–G</b>: CD8⁺ cells display a similar decrease after Que treatment (N = 5, *, <i>p<</i>0.05), but the overall extent of CD8⁺ cells detected was much less than that of CD4⁺ cells. …”

Decreased UFA/SFA ratio induces cytosolic chaperones. by Dongyeop Lee (108880)

The thromboxane analogue, U-46619 decreased vessel diameter. by Simon C. Watkins (39900)

“…Changes in aortic flow velocity (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0044018#pone-0044018-g005" target="_blank">Figure 5</a>) in response to U-46619 in the 5 dpf embryos, were accompanied by decreases in vessel diameter (<b>E</b>, n = 5, <i>P</i><0.05). χ denotes statistical differences from baseline (time 0).…”

VGB decreased activation of the mTOR pathway in vivo. by Bo Zhang (6559)